Skip to content
Loading...
All Sources
All Years

-

Tribute to Dr. Stephen Harrison (1969-2024)

The liver community mourns the loss of Dr. Stephen Harrison, a visionary in MASLD clinics and clinical research, whose contributions have shaped the current state of the field. Dr. Stephen Harrison was…

-

EASL Statement on Resmetirom FDA approval

After over 20 years of dedicated research and drug development, the FDA has granted approval for the first anti-MASH drug. This marks a pivotal moment for patients battling MASH, whose quality of…

Back To Top